COSTS AND EFFECTIVENESS OF IMMUNIZATION PROGRAMS

Similar documents
Vaccines and immunization

Exercise: Estimating immunization program costs (~60 minutes)

Expanded Programme on Immunization (EPI):

Expanded Programme on Immunization. Guidelines for Vaccine Wastage Monitoring Sentinel Project in Ghana

Establishing a second-year-of-life (2YL) healthy child visit

Protocol Synopsis. Administrative information

Systematic review of the non- specific effects of BCG, DTP and measles containing vaccines

Evaluating Immunisation Dropout Rates in Eight Hard to Reach Unions of Maulvibazar District, Bangladesh

Papillomavirus Rapid Interface for Modelling and Economics Tool. User Manual

Psy201 Module 3 Study and Assignment Guide. Using Excel to Calculate Descriptive and Inferential Statistics

Economic Evaluation. Introduction to Economic Evaluation

External Evaluation of the National Immunisation Programme in Bosnia and Herzegovina

Temperature monitors for vaccines and the cold chain

Thailand Expanded Program on Immunization. Suchada Jiamsiri, MD, MPH Division of Vaccine Preventable Diseases Ministry of Public Health, Thailand

VI Child Health. Immunisation

CALIFORNIA CODE OF REGULATIONS TITLE 17, DIVISION 1, CHAPTER 4

7Monitoring and using your data

t^é^t WORLD HEALTH ORGANIZATION _ORGANISATION MONDIALE DE LA SANTÉ

KURUKSHETRA JULY 2017 RURAL HEALTH

OUTCOME AND IMPACT LEVEL INTERVENTION LOGIC & INDICATORS HEALTH SECTOR WORKING PAPER: DRAFT - OCTOBER 2009

Cost of Delivering Child Immunization Services in Urban Bangladesh: A Study Based on Facility-level Surveys

5 $3 billion per disease

Sustaining Immunization in Developing Countries: The Future We Make

Immunization in practice

Polio and measles control: opportunities and threats for health systems

A SURVEY ON IMMUNIZATION COVERAGE AMONG CHILDREN OF RURAL SOUTH KERALA M. C. Vasantha Mallika 1, Siva Sree Ranga M. K 2

The Cost of Routine Immunization Services in a Poor Urban Setting in Kampala, Uganda: Findings of a Facility-Based Costing Study

Fifth report of Committee A

A Tool to Estimate the Potential Impacts for Stockpiling Vaccines for Vaccine-Preventable Diseases of Children

OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE

Daycare, school entry and school program immunization report September Data for school years 2012/13 to 2014/15

Module 7: Part 1 Expanded Programme of Immunization (EPI)

EXPANDED PROGRAM OF IMMUNIZATION (EPI) Definition Program adopted by WHO since l974, it includes child immunization & vaccination of pregnant women.

Setting The study setting was primary care. The economic analysis was conducted in the USA.

Daycare, school entry and school program immunization report. Data for school year 2016/17

Living Today for a Better Tomorrow: Helping Adults Understand the Value of Immunization to Long term Health

Prospective Models for Vaccine Procurement and Security in National Immunization Programmes;

PAPUA NEW GUINEA 330 COUNTRY HEALTH INFORMATION PROFILES. WESTERN PACIFIC REGION HEALTH DATABANK, 2011 Revision. Female. Total. Male.

Increasing immunization coverage at the health facility level

Daycare, school entry and school program immunization report. Data for school year 2015/16

EXPANDED PROGRAM ON IMMUNIZATION (EPI)

Family and Travel Vaccinations

EL CENTRO COLLEGE CENTER FOR ALLIED HEALTH AND NURSING HEALTH OCCUPATIONS ADMISSIONS

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

This document was published by: The National Department of Health. Editorial team: Provincial EPI Team National EPI Team Dr NJ Ngcobo

Impact of Immunization on Under 5 Mortality

Program: Expanding immunization coverage for children

Determinants of Vaccination Status in Rural Guinea-Bissau. Linda Hornshøj

VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE 7. 7

NURTURING CHILDREN IN BODY AND MIND

New Indian Model School Al Garhoud Dubai

THE IMPACT OF PARENTAL EDUCATION AND SOCIOECONOMIC STATUS ON ROUTINE CHILDHOOD VACCINATION: AN OBSEVATIONAL STUDY

6. Making a comprehensive annual national immunization plan and budget

ANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for immunization programme managers

Selected vaccine introduction status into routine immunization

Challenges of building a new vaccine delivery platform for LMICs

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI)

ORIGINAL ARTICLES. Missed opportunities for vaccination in health facilities in Swaziland. Methods

LAO PEOPLE'S DEMOCRATIC REPUBLIC

Manitoba Annual Immunization Surveillance Report

Economic aspects of viral hepatitis in Turkey. Levent AKIN VIRAL HEPATITIS PREVENTION BOARD MEETING ISTANBUL, TURKEY, NOVEMBER 12-13, 2009

Update on Transition: the case of Honduras. Minister Dra Yolani Batres AMRO/EURO Gavi Constituency Representative Geneva June 2016

Mandatory Influenza Vaccination for Healthcare Personnel

Assessment of Immunization Status among Children aged months, at an Urban Slum Area of Jagdalpur City, Bastar

Analyses of Costs and Financing of the Routine Immunization Program and New Vaccine Introduction in the Republic of Moldova.

WESTERN PACIFIC REGION HEALTH DATABANK, 2011 Revision. Total Total. Number of new cases. Total

Database of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2018 University of York.

Pertussis in adolescents and adults: should we vaccinate Lee G M, LeBaron C, Murphy T V, Lett S, Schauer S, Lieu T A

Simplifying pediatric immunization with a fully liquid pentavalent vaccine: Evidence from a time-motion study

6. Making a comprehensive annual national immunization plan and budget

Deadly Imbalance: Social vs Medical Value of Preventative Vaccines

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

Ex post evaluation Tanzania

UNICEF s perspective. WHO Informal Consultation to develop further guidance on vaccines for the UNEP-convened INC4 Geneva, 3-4 April 2012

Child Health Services

Immunization Report Public Health September 2013

MedInform. Ethical and healthcare considerations in relation to mandatory vaccination - Bulgarian perspective. Literature Review

APPENDIX 4 A4.1 APPENDIX 4

Expanded Programme on Immunization (EPI)

Global Health Policy: Vaccines

MUSC Student Pre-Matriculation Requirements Instructions for Completion of Form

Factors for Low Routine Immunization Performance; A Community Based Cross Sectional Study in Dessie Town, South Wollo Zone, Ethiopia, 2014

IOM Committee on Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule

UNIVERSITY OF WISCONSIN-MADISON SCHOOL OF PHARMACY. Health Policies

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

Understanding the Roles of Different Bodies in Vaccine Decision Making: The Caribbean EPI Experience

SCHOOL OF MEDICINE IMMUNIZATION COMPLIANCE FORM

ARKANSAS STATE BOARD OF HEALTH

Johns Hopkins Vaccine Initiative 2013 Vaccine Internship Experience at WHO (VIEW) Sample Internship Descriptions

COMBINATION VACCINE - THE IMPORTANCE AND ROLE IN PUBLIC HEALTH SET UP

Updated WHO position paper on pertussis vaccines. Geneva, Switzerland October 2010

COUPLES DEMOGRAPHIC AND ECONOMIC DIFFERENTIALS: POINTERS TO CHILDHOOD COMPLETE IMMUNIZATION UPTAKE IN NIGERIA.

Vaccine Storage in Remote Areas

January 2005 Addis Ababa, Ethiopia

NHS public health functions agreement Service specification No.9 DTaP/IPV and dtap/ipv pre-school booster immunisation programme

Mandates and More. Julie Morita, M.D. Deputy Commissioner Chicago Department of Public Health. Chicago Department of Public Health

Transcription:

Department of Epidemiology Course EPI 415 School of Public Health University of California, Los Angeles Session 15 COSTS AND EFFECTIVENESS OF IMMUNIZATION PROGRAMS I. INTRODUCTION A. Immunization lends itself well to the assessment of effectiveness 1. Link between input, output, effect and impact is reasonably well understood 2. Many publications are available to guide the cost analysis a. Typically emphasize using economic appraisal as a means for... (1) assessing the efficiency of existing immunization delivery (2) determining the choice of strategies for expanding coverage B. Use immunization program models that link cost to health outcomes 1. Encourages the decision-maker to... a. establish relationships between cost, program efforts and disease outcomes (1) Use existing knowledge of financial systems (2) Use biomedical knowledge b. rationally discuss merits of various program alternatives (1) Analytic rather than a political c. estimate the magnitude of the various parameters in the model (1) Determine necessary information for future surveys, etc. 2. Use to test assumptions and see how changes affect the outcomes a. Least costly way to do experiments C. Cost-effectiveness models for microcomputers 1. "What if" analyses a. Sensitivity analysis (1) Determine how sensitive the outcome of interest is to varying values of input parameters. (2) Example: Vijayaraghavean M, et al. Disasters 30(2), 256-269, 2006 b. Spreadsheet programs such as Excel or Quattro 2. Present the results in graphic form a. Easier to observe the main trends or patterns -1-

3. Guides rather than directs program planner or policy-maker a. Seeing resultants on the computer monitor is often more convincing than having a "heated" political discussion b. Promotes self-learning rather than having to rely on the opinions or interpretations of staff members (1) Spreadsheet models are easy to work with, once they have been correctly set up by the technical staff II. ESTABLISHING COSTS A. Problem areas 1. Proportion of variable and fixed costs to be attributed to the immunization program a. Problem in multi-purpose programs where health personnel doing many different tasks b. Variable (or operating) costs (1) Costs that vary with the number of administered vaccine doses (a) Clinics immunizing 500 children per year have a lower operating cost than clinics immunizing 1,000 children per year c. Fixed costs (1) Costs that do not vary with the number of administered vaccine doses (a) Tend to remain fixed for an entire year (b) Clinics immunizing 500 children per year may have the same fixed cost as clinics immunizing 1,000 children per year 2. Need to correct for distorted or inappropriate domestic market prices a. Establish shadow prices to more realistically deal with subsidized vaccine production costs (1) Price set by economists to reflect the true value to society of an item or program when not traded in a free market (a) True cost of establishing and operating the program elsewhere b. Include cost of donations from outside agencies B. Budget categories 1. Personnel a. Salaries of supervisors, immunization team and support staff b. Both variable and fixed costs 2. Facilities a. Buildings such as hospitals or rural health centers b. Fixed costs -2-

3. Materials and equipment a. Vaccines, furnishings, etc. b. Both variable and fixed costs 4. Miscellaneous a. Vehicles and fuel for vehicles b. Other unclassified items c. Both variable and fixed costs 5. Patient inputs a. Transportation and food costs for those accompanying the patient b. Variable costs III. ESTABLISHING THE LEVEL OF EFFECTIVENESS A. Need to create a single outcome measure 1. Measures of output a. Number of administered vaccine doses b. Number of fully vaccinated children (1) Developed country example (USA) (a) MMWR 57 (01), Q1-Q4, Jan. 11, 2008. Figure 1. Recommended young child (0-6 years) immunization schedule, United States 2008. (2) Developing country example (8 doses) (a) DPT - 3 doses per child (b) OPV - 3 doses per child (c) BCG - 1 dose per child (d) Measles - 1 dose per child -3-

2. Measure of effect a. Number of children with four-fold increases in immune titer (1) Based on serological evidence (paired sera) 3. Measures of impact a. Prevented morbidity (1) Cases (2) Rates (cases per unit population per time period of interest) b. Prevented mortality (1) Deaths (2) Rates (deaths per unit population per time period of interest) c. Reduction in days of healthy life lost (DHLL) (1) Days (or years) of healthy life gained (DHLG or YHLG) (2) Rates (annual DHLL, DHLG or YHLG per 1,000 population) d. Reduction in disability-adjusted life years (DALYs) lost (1) Not covered in this lecture, but extension of DHLL concept B. Derivations 1. Number of prevented cases a. Required data (1) Annual number of vaccinated children (a) Count tally sheets of immunization clinic or program (b) Estimate indirectly +) ), * Neonatal * Number of Total Crude * mortality * Proportion vaccinated = population x birth rate* x * 1 - rate* in * x of children children in service in service * service * vaccinated per year area area * area *.) )- -4-.)))))))))))))))))))))))))))))0))))))))))))))))))))))))))))))- estimates the number of children, aged 0-1 year, available for immunization * measured as a proportion (2) Background incidence with no vaccination Figure 2. Cumulative incidence among unvaccinated children during time of immunity.

(3) Vaccine effectiveness (a) Estimate based on prior studies (b) Conduct a field survey b. Calculation Background Number of Number of cumulative Vaccine prevented = vaccinated x incidence* x effectiveness* cases children during period of immunity -5-.))))))))))))))))))))))0))))))))))))))))))- expected cases during period of of immunity if these children had not been immunized * measured as a proportion 2. Number of prevented deaths a. Required data (1) Number of prevented cases (a) Derived above (2) Case-fatality proportion (a) Proportion of deaths due to the disease among incident cases (b) Estimated from clinical experience (c) Derived in follow-up studies of incident cases b. Calculation Number of Number of Case prevented = prevented x fatality deaths cases proportion 3. Days of healthy life gained (DHLG) a. Required data (1) Number of prevented cases (a) Derived above (2) Days of healthy life lost (DHLL) per case (a) See Ghana, 1981 reference article for details b. Calculation Days of Number of Days of healthy life = prevented x healthy life gained cases lost per case 4. Years of healthy life gained (YHLG) a. Calculation Years of 1 Number of Days of healthy life = ))))) x prevented x healthy life gained 365 cases lost per case

IV. ESTABLISHING THE LEVEL OF COST-EFFECTIVENESS A. Need to link program cost with a measure of effectiveness 1. Derive present value for all future program costs so that comparisons can be made between one program and another B. Measures relating input to output 1. Cost per vaccine dose a. Derivation Present value of average annual cost Annual cost of vaccination program per = ))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) vaccine dose +, +, +, * Total * * Proportion * * Average no. of * * population * x *of children * x * vaccine doses * * of children* * vaccinated * * given by program* *. -. -. - * usually up to 8 doses (3 of DPT, 3 of OPV, 1 of BCG and 1 of measles) (1) Assumes the cost per dose of vaccine is distributed equally among all doses of the vaccine 2. Cost per fully vaccinated child a. Calculation is specific to a vaccine (1) For DPT, fully vaccinated is 3 doses (a) If a total of 8 doses of vaccine are given by the program, the cost for DPT should be 3/8ths of the total cost (2) For OPV, fully vaccinated is 3 doses (a) The cost for OPV should be 3/8ths of the total cost (3) For BCG, fully vaccinated is 1 dose (a) The cost for BCG should be 1/8th of the total cost (4) For Measles, fully vaccinated is 1 dose (a) The cost for Measles should be 1/8th of the total cost b. Derivation +, * Number of doses * * for the * * specified vaccine * * Present value of average annual cost Annual cost. - of vaccination program per fully = )))))))))))))))))))))))))))))))) x ))))))))))))))))))))))))))))))))))))))))))))))) vaccinated* +, +, +, child * Average no. of * * Total * * Proportion * * vaccine doses * * population * x * of children * * given by program # * * of children * * vaccinated *. -. -. - -6-

* either 3 for DPT, 3 for OPV, 1 for BCG or 1 for measles # usually 8 doses C. Measures relating input to effect 1. Cost per seroconverted case a. May be measured in the future with saliva D. Measures relating input to impact 1. Cost per prevented case (vaccine-specific) a. Derivation +, +, * Number of doses * * Present value of * * for the * * average annual cost * * specified vaccine ** * of vaccination program * Annual cost. -. - per prevented = ))))))))))))))))))))))))))))) x ))))))))))))))))))))))))))))))))))))))) case +, +, * Average no. of * * Number of prevented cases * * vaccine doses * * among the children vaccinated * * given by program # * * during a given year @ *. -. - * either 3 for DPT, 3 for OPV, 1 for BCG or 1 for measles # usually 8 doses @ for DPT, includes prevented cases of diphtheria, pertussis and tetanus -7-

2. Cost per prevented case (disease-specific) a. Derivation +, +, * Number of vaccine * * Present value of * * doses for the * * average annual cost * * specified disease ** * of vaccination program * Annual cost. -. - per prevented = )))))))))))))))))))))))))))))))))))))))))))))))))) x )))))))))))))))))))))))))))))))))))))) case +, +, +, * Average no. of * * Number of shared * * Number of prevented cases * * vaccine doses * * diseases for * * among the children vaccinated * * given by program # * * the vaccine @ * * during a given year *. -. -. - * either 3 for DPT, 3 for OPV, 1 for BCG or 1 for measles # usually 8 doses @ 3 for DPT and 1 for OPV, BCG and measles cases of either diphtheria, pertussis, tetanus, poliomyelitis, tuberculosis or measles 3. Cost per prevented death (vaccine-specific) a. Derivation +, +, * Number of doses * * Present value of * * for the * * average annual cost * * specified vaccine ** * of vaccination program * Annual cost. -. - per prevented = )))))))))))))))))))))))))))) x ))))))))))))))))))))))))))))))))))))))) deaths +, +, * Average no. of * * Number of prevented deaths * * vaccine doses * * among the children vaccinated * * given by program # * * during a given year @ *. -. - * either 3 for DPT, 3 for OPV, 1 for BCG or 1 for measles # usually 8 doses @ for DPT, includes prevented deaths due to diphtheria, pertussis and tetanus 4. Cost per prevented death (disease-specific) a. Derivation +, +, * Number of vaccine * * Present value of * * doses for the * * average annual cost * * specified disease ** * of vaccination program * Annual cost. -. - per prevented = ))))))))))))))))))))))))))))))))))))))))))))))))))) x ))))))))))))))))))))))))))))))))))))))) death +, +, +, * Average no. of * * Number of shared * * Number of prevented deaths * * vaccine doses * * diseases for * * among the children vaccinated * * given by program # * * the vaccine @ * * during a given year *. -. -. - * either 3 for DPT, 3 for OPV, 1 for BCG or 1 for measles # usually 8 doses @ 3 for DPT and 1 for OPV, BCG and measles deaths due to either diphtheria, pertussis, tetanus, poliomyelitis, tuberculosis or measles -8-

5. Cost per day of healthy life gained (vaccine-specific) a. Derivation +, +, * Number of doses * * Present value of * * for the * * average annual cost * * specified vaccine ** * of vaccination program * Annual cost. -. - per day of = )))))))))))))))))))))))))))) x )))))))))))))))))))))))))))))))))))))))))))))))))))))) healthy life +, +, gained * Average no. of * * Number of days of healthy life gained due to * * vaccine doses * * the prevention of the disease among children * * given by program # * * vaccinated during a given year @ *. -. - * either 3 for DPT, 3 for OPV, 1 for BCG or 1 for measles # usually 8 doses @ for DPT, includes days of healthy life gained due to the prevention of diphtheria, pertussis and tetanus 6. Cost per day of healthy life gained (disease-specific) a. Derivation +, +, * Number of doses * * Present value of * * for the * * average annual cost * * specified vaccine ** * of vaccination program * Annual cost. -. - per day of = ))))))))))))))))))))))))))))))))))))))))))))))))) x )))))))))))))))))))))))))))))))))))))))))))))))))))))) healthy life +, +, +, gained * Average no. of * * Number of shared * * Number of days of healthy life gained due to * * vaccine doses * * diseases for * * the prevention of the disease among children * * given by program # * * the vaccine @ * * vaccinated during a given year *. -. -. - * either 3 for DPT, 3 for OPV, 1 for BCG or 1 for measles # usually 8 doses @ 3 for DPT and 1 for OPV, BCG and measles DHLG for either diphtheria, pertussis, tetanus, poliomyelitis, tuberculosis or measles 7. Cost per year of healthy life gained (vaccine-specific) a. Derivation +, +, * Number of doses * * Present value of * * for the * * average annual cost * * specified vaccine ** * of vaccination program * Annual cost. -. - per year of = 365 x ))))))))))))))))))))))))))) x ))))))))))))))))))))))))))))))))))))))))))))))))))))) healthy life +, +, gained * Average no. of * * Number of days of healthy life gained due to * * vaccine doses * * the prevention of the disease among children * * given by program # * * vaccinated during a given year @ *. -. - * either 3 for DPT, 3 for OPV, 1 for BCG or 1 for measles # usually 8 doses @ for DPT, includes days of healthy life gained due to the prevention of diphtheria, pertussis and tetanus -9-

8. Cost per year of healthy life gained (disease-specific) a. Derivation +, +, * Number of doses * * Present value of * * for the * * average annual cost * * specified vaccine ** * of vaccination program * Annual cost. -. - per year of = 365 x ))))))))))))))))))))))))))))))))))))))))))))))))) x )))))))))))))))))))))))))))))))))))))))))))))))))))))) healthy life +, +, +, gained * Average no. of * * Number of shared * * Number of days of healthy life gained due to * * vaccine doses * * diseases for * * the prevention of the disease among children * * given by program # * * the vaccine @ * * vaccinated during a given year *. -. -. - * either 3 for DPT, 3 for OPV, 1 for BCG or 1 for measles # usually 8 doses @ 3 for DPT and 1 for OPV, BCG and measles DHLG for either diphtheria, pertussis, tetanus, poliomyelitis, tuberculosis or measles V. EXAMPLE USING EXCEL A. Estimate the cost-effectiveness of childhood immunization programs for the child population in some specified service area 1. See Appendix for the complete set of 4 tables B. Input data 1. Total population in service area 2. Crude birth rate in service area 3. Neonatal mortality rate in service area 4. Duration of program planning period (in years) 5. Annual discount rate for program costs 6. DHLL estimates 7. Expected duration of immunity due to the vaccine (in years) 8. Expected cumulative incidence among unvaccinated persons during the duration time of immunity 9. Proportion of the population which is vaccinated 10. Estimated vaccine effectiveness 11. Annual itemized costs -10-

a. Personnel b. Facilities c. Materials and equipment d. Miscellaneous e. Patient inputs C. Create the spreadsheet program (see Appendix for output) 1. Entries and formulas for top portion of the spreadsheet (above Table 1) A B C D E F G 1 COST-EFFECTIVENESS OF CHILDHOOD IMMUNIZATION PROGRAMS 2 3 Total population in service area = 2,360,000 Neonatal mortality in service area = 0.024 4 5 Crude birth rate in service area = 0.032 Expected eligible child population in 6 the service area per year = =B3*B5*(1-G3) 7 Duration of program planning 8 period (in years) = 5 Annual Discount Rate for Program Costs = 0.085 2. Entries and formulas for Table 1 -- middle portion (see Appendix) A ))))))))))))))))))))))))))))))))))))))))) 34 DAYS OF HEALTHY LIFE LOST PER CASE =), ))))))))))))))))))))))))))))))))))))))))) * +))))))))))))))))))))))))))))))))))))))))))))-? B )))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 34 =(B19*365*((B17-(B21-B15))+((B21-B15)*B23)))+(B25*B17*B27*365)+((1-B19-B25)*B29*B32) )))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) A B ))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 46 DUE TO THE IMMUNIZATION PROGRAM... 47 Note: the same relative formulas 48 Number of prevented cases =$G$6*B$42*B$40*B$44 for columns C - G; use $ 49 to copy the unchanged 50 Number of prevented deaths =B$48*B$19 row references 51 52 Days of healthy life gained =B$34*B$48 53 54 Years of healthy life gained =B$52/365 55 ))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 56 3. Entries and formulas Table 2 -- bottom portion (see Appendix) A B ))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 75 ANNUAL PROGRAM COSTS 76 77 Total =SUM(B$65:B$73) 78 79 Average =AVG(B77:F77) 80 81 Present Value of Average =NPV(G8,B77:F77)/B8 82 444444444444444444444444444444444444444444444444444444444444444444444444444444444444 83-11-

4. Entries and formulas for Table 3 (see Appendix) A B C D E F 84 85 Table 3. Cost-effectiveness of immunization program by type of vaccine, xx Region. 86 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 87 Type of Vaccine ))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 88 Unit Costs DPT OPV BCG Measles Total 444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 89 90 Cost per Vaccine Dose =$B$81/($G$6*$B$42*8) =$B$81/($G$6*$B$42*8) =$B$81/($G$6*$B$42*8) =$B$81/($G$6*$B$42*8) =SUM(B90:E90) 91 92 Cost per Fully Vaccinated Child =(3/8*$B$81)/($G$6*$B$42) =(3/8*$B$81)/($G$6*$B$42) =(1/8*$B$81)/($G$6*$B$42) =(1/8*$B$81)/($G$6*$B$42) =SUM(B92:E92) 93 94 Cost per Prevented Case =(3/8*B81)/SUM(B48:D48) =(3/8*B81)/E48 =(1/8*B81)/F48 =(1/8*B81)/G48 =SUM(B94:E94) 95 96 Cost per Prevented Death =(3/8*B81)/SUM(B50:D50) =(3/8*B81)/E50 =(1/8*B81)/F50 =(1/8*B81)/G50 =SUM(B96:E96) 97 98 Cost per Day of Healthy Life Gained =(3/8*B81)/SUM(B52:D52) =(3/8*B81)/E52 =(1/8*B81)/F52 =(1/8*B81)/G52 =SUM(B98:E98) 99 100 Cost per Year of Healthy Life Gained =(365*3/8*B81)/SUM(B52:D52) =(365*3/8*B81)/E52 =(365*1/8*B81)/F52 =(365*1/8*B81)/G52 =SUM(B100:E100) 101 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 102 5. Entries and formulas Table 4 (see Appendix) A B C D E F G 103 104 Table 4. Cost-effectiveness of immunization program by specific disease, xx Region. 105 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 106 Target Diseases ))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 107 Diphtheria Pertussis Tetanus Poliomyelitis Tuberculosis Measles 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 108 109 Cost of Program =(3/(8*3))*B81 =(3/(8*3))*B81 =(3/(8*3))*B81 =(3/(8*1))*B81 =(1/(8*1))*B81 =(1/(8*1))*B81 110 111 Cost per Prevented Case =B$109/B$48 =C$109/C$48 =D$109/D$48 =E$109/E$48 =F$109/F$48 =G$109/G$48 112 113 Cost per Prevented Death =B$109/B$50 =C$109/C$50 =D$109/D$50 =E$109/E$50 =F$109/F$50 =G$109/G$50 114 115 Cost per Year of Healthy Life Gained =B$109/B$54 =C$109/C$54 =D$109/D$54 =E$109/E$54 =F$109/F$54 =G$109/G$54 116 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 117-12-

D. Create graphs to promote rapid understanding of the results 1. Use the graph function of Excel 2. Example showing results from output in Appendix a. Cost per prevented case (vaccine-specific) 500 400 Cost ($) 300 200 100 0 DPT OPV BCG Measles Vaccine Figure 3. Cost per prevented case by type of vaccine. (1) For DPT, prevented cases of diphtheria, pertussis or tetanus during the following 10 years (i.e., the duration of immunity) (2) For OPV, prevented cases of poliomyelitis during the life of the child (estimated as 60 years in the spreadsheet) (3) For BCG, prevented cases of tuberculosis during the following 15 years (4) For measles, prevented cases of measles during the life of the child (also estimated as 60 years in the spreadsheet) b. Cost per prevented death (vaccine-specific) 10 Cost (x $1,000) 8 6 4 2 0 DPT OPV BCG Measles Vaccine Figure 4. Cost per prevented death, by type of vaccine -13-

c. Cost per year of healthy life gained (vaccine-specific) 30 25 Cost ($) 20 15 10 5 0 DPT OPV BCG Measles Vaccine Figure 5. Cost per year of healthy life gained, by type of vaccine. d. Cost per year of healthy life gained (disease-specific) 80 Cost ($) 70 60 50 40 30 20 10 0 Diphtheria Pertussis Tetanus Poliomyelitis Tuberculosis Measles Disease Figure 6. Cost per year of healthy life gained, for selected diseases. VI. CONCLUDING REMARKS ON COST-EFFECTIVENESS ANALYSIS A. Advantages of spreadsheet model for planning immunization strategies 1. Provides insight based on known information a. Use existing data for cost and disease components b. Determine effect of known values on cost and disease outcomes 2. Indicates areas of further research -14-

a. Focus on parameters of disagreement b. Do sensitivity analysis for parameters in question (1) Determine effect on conclusions (2) If effect is pronounced, conduct additional field studies B. Disadvantage for planning immunization strategies 1. The results of cost-effectiveness analyses do not always indicate the best decision to be made a. Strategies with the lowest cost for the most effect may not fully reflect the social values of the society b. The benefits of an alternative strategy may be much greater than the selected policy (1) Using effectiveness rather than benefits as the consequence of the immunization strategy may provide too narrow a focus and lead to the implementation of a less desirable strategy -15-

APPENDIX A B C D E F G 1 COST-EFFECTIVENESS OF CHILDHOOD IMMUNIZATION PROGRAMS 2 3 Total population in service area = 2,360,000 Neonatal mortality in service area =.024 4 5 Crude birth rate in service area =.032 Expected eligible child population in 6 the service area per year = 73,708 7 Duration of program planning 8 period (in years) = 5 Annual Discount Rate for Program Costs =.085 9 10 11 Table 1. Days of healthy life gained in the service area population due to the immunization program, xx Region. 12 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 13 EPI Target Diseases ))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 14 DHLL Formula Component Diphtheria Pertussis Tetanus Poliomyelitis Tuberculosis Measles 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 15 Av. age of disease onset 3 1 15 3 20 2 16 17 Av. life exp. at disease onset 53.0 52.4 46.5 52.0 42.5 53.0 18 19 Av. case-fatality.07.01.35.05.35.03 20 21 Av. age at death due to disease 3 1 15 3 25 2 22 23 Prop. disablement prior to death.25 24 25 Av. case-disability.95 26 27 Prop. disablement among disabled.25 28 29 Days of temporary disability 37 37 32 400 26 30 31 Prop. disablement during 32 temp. disability days.80.80.95.50.80 33 )))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 34 DAYS OF HEALTHY LIFE LOST PER CASE 1,382 221 5,960 5,457 5,080 601 )))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 35 36 Exp. duration of immunity (years) 10 10 10 60 15 60 37 38 Expected cumulative incidence 39 among UNVACCINATED persons during 40 duration time of immunity.0050.2000.0080.0100.0300.9000 41 42 Proportion of population vaccinated.70.70.70.70.95.85 43 44 Estimated vaccine effectiveness.85.85.85.80.50.80-16-

Table 1. Days of healthy life gained in the service area population due to the immunization program, xx Region (continued). A B C D E F G 45 )))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 46 DUE TO THE IMMUNIZATION PROGRAM... 47 48 Number of prevented cases 219 8,771 351 413 1,050 45,109 49 50 Number of prevented deaths 15 88 123 21 368 1,353 51 52 Days of healthy life gained 302,974 1,934,610 2,091,100 2,252,340 5,336,016 27,089,129 53 54 Years of healthy life gained 830 5,300 5,729 6,171 14,619 74,217 55 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 56 57 58 Table 2. Cost of the immunization program, xx Region. 59 4444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 60 Year of Program Activities ))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 61 Budget Categories Year 1 Year 2 Year 3 Year 4 Year 5 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 62 63 ANNUAL ITEMIZED COSTS 64 65 Personnel $260,400 $270,200 $277,900 $287,350 $290,920 66 67 Facilities $84,000 $56,000 $64,400 $67,200 $68,600 68 69 Materials and Equipment $169,400 $147,000 $158,200 $171,500 $173,600 70 71 Miscellaneous $15,400 $21,700 $10,920 $12,740 $13,300 72 73 Patient Inputs $3,150 $3,920 $4,410 $5,180 $5,740 74 ))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 75 ANNUAL PROGRAM COSTS 76 77 Total $532,350 $498,820 $515,830 $543,970 $552,160 78 79 Average $528,626 80 81 Present Value of Average $450,914 82 4444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 83-17-

A B C D E F G 84 85 Table 3. Cost-effectiveness of immunization program by type of vaccine, xx Region. 86 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 87 Type of Vaccine )))))))))))))))))))))))))))))))))))))))))))))))))))) 88 Unit Costs DPT OPV BCG Measles Total 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 89 90 Cost per Vaccine Dose $1.09 $1.09 $1.09 $1.09 $4.37 91 92 Cost per Fully Vaccinated Child $3.28 $3.28 $1.09 $1.09 $8.74 93 94 Cost per Prevented Case $18.10 $409.66 $53.66 $1.25 $482.68 95 96 Cost per Prevented Death $748.67 $8,193.23 $153.32 $41.65 $9,136.87 97 98 Cost per Day of Healthy Life Gained $.04 $.08 $.01 $.00 $.13 99 100 Cost per Year of Healthy Life Gained $14.26 $27.40 $3.86 $.76 $46.28 101 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 102 103 104 Table 4. Cost-effectiveness of immunization program by specific disease, xx Region. 105 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 106 Target Diseases ))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) 107 Diphtheria Pertussis Tetanus Poliomyelitis Tuberculosis Measles 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 108 109 Cost of Program $56,364.24 $56,364.24 $56,364.24 $169,092.71 $56,364.24 $56,364.24 110 111 Cost per Prevented Case $257.04 $6.43 $160.65 $409.66 $53.66 $1.25 112 113 Cost per Prevented Death $3,672.04 $642.61 $459.00 $8,193.23 $153.32 $41.65 114 115 Cost per Year of Healthy Life Gained $67.90 $10.63 $9.84 $27.40 $3.86 $.76 116 44444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 117-18-